As we observed indications of attenuated NAFLD development in the HFD-fed Tlcd1/2 DKO mice compared to controls, we hypothesized that Tlcd1/2 deletion may also be protective against NASH in mice. This evidence concerns the gene TLCD1 and metabolic dysfunction-associated steatotic liver disease.